CHEK2 and familial papillary or follicular thyroid carcinoma: Mutations in CHEK2 not only exist in subsets of sporadic cancers, but they also predispose patients to several types of familial cancers (29), with increasing evidence emerging in the context of FNMTC (21, 22, 23, 24, 25).